Healthy adult
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Males and females aged 30 to 65 at the time of informed consent 2) Those with a BMI of 18.5 kg/m2 or more and less than 30.0 kg/m2 3) Subjects who have received a sufficient explanation of the purpose and content of the study and have signed a consent form before the start of the study
Exclusion criteria
Exclusion criteria: 1) bowel disease (irritable bowel syndrome, Crohn's disease), liver disease, kidney disease, cardiovascular disease (brain and heart), diabetes, dyslipidemia, hypertension, epileptic seizures, sleep apnea, and other chronic diseases Those who are undergoing drug treatment due to past medical history or current medical history 2) Those who have a history of gastrointestinal surgery 3) Subjects who regularly use health foods that may affect inspection items 4) Subjects who cannot stop taking pharmaceuticals, quasi-drugs, and health foods from obtaining consent until the end of the study 5) heavy alcohol drinker 6) Those who have extremely irregular eating habits 7) Shift workers or late-night workers 8) a person who regularly uses some kind of drug 9) Subjects who plan to receive treatment during the intake period of the test food 10) Subjects with perennial atopic dermatitis or rhinitis 11) Those who have a history of anaphylactic shock in the past 12) Subjects judged inappropriate by the investigator and subinvestigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the curve of blood glucose level | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood glucose level Postprandial blood glucose level (30, 60, 90, 120 min) maximum blood glucose level | — |
Countries
Japan
Contacts
Medical Corporation Kyoso-kai AMC Nishi-Umeda Clinic Department of Clinical Research Center